PARK AVENUE SECURITIES LLC

Broker-Dealer

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1071640 NEW YORK, NY

Position in TEVA

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$650,191

+$77,309 QoQ

Shares Held

19,191

+0.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#373

of 671 holders

Holding Since

Sep 2022

10 quarters on record

Healthcare · as of Jun 30, 2026

PARK AVENUE SECURITIES LLC holds $5,937,881 across 8 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (10.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	8,601	$1,449,612
2	HLN	Haleon plc	111,923	$1,044,241
3	KNSA	Kiniksa Pharmaceuticals International, plc	14,734	$942,239
4	TAK	Takeda Pharmaceutical Co Ltd	44,827	$718,576
5	TEVA	Teva Pharmaceutical Industries Ltd This page	19,191	$650,191
6	UTHR	UNITED THERAPEUTICS Corp	1,038	$562,419
7	ZTS	Zoetis Inc.	4,994	$358,868
8	AMRX	Amneal Pharmaceuticals, Inc.	12,232	$211,735

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$650,191	19,191	+0.9%	Shares	Sole	2026-07-20
2026-03-31	$572,882	19,020	+70.2%	Shares	Sole	2026-04-07
2025-12-31	$348,771	11,175	+0.5%	Shares	Sole	2026-01-05
2025-09-30	$224,644	11,121	-4.1%	Shares	Sole	2025-10-23
2025-03-31	$178,276	11,599	-6.7%	Shares	Sole	2025-04-14
2024-12-31	$274,045	12,434	+23.2%	Shares	Sole	2025-01-14
2024-09-30	$181,875	10,093	-13.3%	Shares	Sole	2024-10-03
2024-06-30	$189,133	11,639	-33.8%	Shares	Sole	2024-07-09
2024-03-31	$247,983	17,575	+48.3%	Shares	Sole	2024-04-10
2022-09-30	$95,629	11,850	—	Shares	Sole	2022-11-01
No filing history on record for this holder in this stock.